Your browser doesn't support javascript.
loading
CXCL1 Clone Evolution Induced by the HDAC Inhibitor Belinostat Might Be a Favorable Prognostic Indicator in Triple-Negative Breast Cancer.
Han, Xin-le; Du, Jun; Zheng, Ya-Dan; Dai, Jia-Jing; Lin, Su-Wen; Zhang, Bing-Yue; Zhong, Fu-Bo; Lin, Zhe-Guang; Jiang, Shu-Qi; Wei, Wei; Fang, Zheng-Yu.
Afiliação
  • Han XL; Biomedical Research Institute, Shenzhen Peking University-The Hong Kong University of Science and Technology Medical Center, Shenzhen, Guangdong 518036, China.
  • Du J; State Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Disease Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin 300020, China.
  • Zheng YD; Biomedical Research Institute, Shenzhen Peking University-The Hong Kong University of Science and Technology Medical Center, Shenzhen, Guangdong 518036, China.
  • Dai JJ; Biomedical Research Institute, Shenzhen Peking University-The Hong Kong University of Science and Technology Medical Center, Shenzhen, Guangdong 518036, China.
  • Lin SW; Biomedical Research Institute, Shenzhen Peking University-The Hong Kong University of Science and Technology Medical Center, Shenzhen, Guangdong 518036, China.
  • Zhang BY; Biomedical Research Institute, Shenzhen Peking University-The Hong Kong University of Science and Technology Medical Center, Shenzhen, Guangdong 518036, China.
  • Zhong FB; Biomedical Research Institute, Shenzhen Peking University-The Hong Kong University of Science and Technology Medical Center, Shenzhen, Guangdong 518036, China.
  • Lin ZG; Department of Biobank, Peking University Shenzhen Hospital, Shenzhen, Guangdong 518036, China.
  • Jiang SQ; Department of Biobank, Peking University Shenzhen Hospital, Shenzhen, Guangdong 518036, China.
  • Wei W; Department of Thyroid and Breast Surgery, Peking University Shenzhen Hospital, Shenzhen, Guangdong 518036, China.
  • Fang ZY; Biomedical Research Institute, Shenzhen Peking University-The Hong Kong University of Science and Technology Medical Center, Shenzhen, Guangdong 518036, China.
Biomed Res Int ; 2021: 5089371, 2021.
Article em En | MEDLINE | ID: mdl-33959656
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sulfonamidas / Quimiocina CXCL1 / Inibidores de Histona Desacetilases / Neoplasias de Mama Triplo Negativas / Ácidos Hidroxâmicos Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Female / Humans Idioma: En Revista: Biomed Res Int Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sulfonamidas / Quimiocina CXCL1 / Inibidores de Histona Desacetilases / Neoplasias de Mama Triplo Negativas / Ácidos Hidroxâmicos Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Female / Humans Idioma: En Revista: Biomed Res Int Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China País de publicação: Estados Unidos